Where do you see your premiums in FY25?
We plan to finish at around Rs 42,000-43,000 crore for FY25, up 15-16 per cent from last year at Rs 37,000 crore, driven by the health segment to a great extent. Retail health is something where you would normally not see too much reinsurance support since ticket size is small. But that is where we have looked to grow and we have managed that growth. Group health is not something where we have appetite.
How do you see growth in the health portfolio amid rising claims and medical inflation?
Retail health is a good area to be in, mainly because loss ratios are decent at around 50-60 per cent. There will be acquisition costs of about 40 per cent. So, you are still making profits and for an insurance company, it is an area where they are doing well. Yes, there is medical inflation. It is all a question of how you price it. Once you price it well, there is a good chance for that portfolio to do well.